ArticleJournal of experimental & clinical cancer research : CR2021

Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.

Stuart R Pierce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.